4//SEC Filing
Payne Joseph E 4
Accession 0001104659-21-073495
CIK 0001824293other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 8:37 PM ET
Size
7.1 KB
Accession
0001104659-21-073495
Insider Transaction Report
Form 4
Payne Joseph E
Director10% Owner
Transactions
- Purchase
Common Stock
2021-05-25$3.85/sh+10,700$41,195→ 10,700 total - Purchase
Common Stock
2021-05-26$4.50/sh+6,800$30,600→ 17,500 total
Holdings
- 843,750(indirect: By Arcturus Therapeutics, Inc.)
Common Stock
Footnotes (1)
- [F1]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
Vallon Pharmaceuticals, Inc.
CIK 0001824293
Entity typeother
Related Parties
1- filerCIK 0001727315
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 8:37 PM ET
- Size
- 7.1 KB